bpc-157 compound FDA panel backs compounded BPC-157, KPV peptides in win for RFK Jr Bpc-157 | C62H98N16O22 | CID

Common symptoms include: Chronic bloating and abdominal distension Excessive gas (flatulence or belching) Abdominal pain or cramping Diarrhea, constipation, or alternating bowel habits Nausea or early satiety Malabsorption of nutrients (especially B12, iron, and fat-soluble vitamins) Fatigue or brain fog Unintentional weight loss Symptoms worsened by probiotics or high-fiber foods Because of its vague presentation, SIBO is frequently misdiagnosed as irritable bowel syndrome (IBS)yet up to 80% of people with IBS may actually have SIBO

S., McCormick, A., & Uretz, E

Yes , for any in vitro biological assay where the reconstituted peptide is added to cell cultures or tissue preparations, matched Bacteriostatic Water vehicle controls at the same final benzyl alcohol concentration as the highest peptide treatment concentration should be included to confirm absence of benzyl alcohol-mediated biological effects on the assay endpoints measured

They mean the FDA found problems during inspections